Get the Stockscreener App
13.19
0.84%
+0.11
Pre-market:
13.2882
0.0982
+0.74%
Takeda Pharmaceutical Co ADR Stock (TAK) Forecast
The Takeda Pharmaceutical Co ADR (TAK) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $10.65, representing a -19.28% decrease from the current price of $13.19. The highest analyst price target is $11.40, and the lowest is $9.8899.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TAK Price Target
Average 10.37
(-21.36% Downside)
Is Takeda Pharmaceutical Co ADR (TAK) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.49 | Neutral |
| STOCH(9,6) | 23.89 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.237 | Buy |
| ADX(14) | 34.29 | Sell |
| William %R | -66.67 | Neutral |
| CCI(14) | -26.82 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
13.19
Sell
|
13.20
Sell
|
| MA20 |
13.32
Sell
|
13.36
Sell
|
| MA50 |
13.98
Sell
|
13.76
Sell
|
| MA100 |
14.18
Sell
|
14.08
Sell
|
| MA200 |
14.54
Sell
|
14.53
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, TAK could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on TAK, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.49 indicates that TAK is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 23.89 indicates that TAK is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that TAK is oversold. This suggests that TAK price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.29 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -26.82 indicates that TAK is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TAK price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Takeda Pharmaceutical Co ADR financial reports and earnings history, Takeda Pharmaceutical Co ADR (TAK) stock could reach $6.665 by 2030, $2.4934 by 2040 and $11.89 by 2050. See the projected annual prices until 2050 of the Takeda Pharmaceutical Co ADR stock below:
- Takeda Pharmaceutical Co ADR (TAK) is expected to reach an average price of $4.823 in 2035, with a high prediction of $4.883 and a low estimate of $4.0531. This indicates an $-63.43% rise from the last recorded price of $13.19.
- Takeda Pharmaceutical Co ADR (TAK) stock is projected to chart a bullish course in 2040, with an average price target of $2.0008, representing an $-84.83% surge from its current level. The forecast ranges from a conservative $1.6984 to a sky-high $2.4934.
- Our analysts predict Takeda Pharmaceutical Co ADR (TAK) to jump -44.65% by 2045, soaring from $7.2204 to an average price of $7.3005, potentially reaching $7.3405. While $7.2204 is the low estimate, the potential upside is significant.
- Takeda Pharmaceutical Co ADR (TAK) stock is expected to climb by 2050, reaching an average of $11.69, a $-11.40% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.89 and $11.87, respectively, highlighting the market's uncertainty.
Takeda Pharmaceutical Co ADR Stock (TAK) Year by Year Forecast
Takeda Pharmaceutical Co ADR Stock (TAK) Price Forecast for 2024
Our forecast for TAK stock price in 2024 now indicates an average price target of $12.35 with a high forecast of $15.07 and a low forecast of $9.6273. The average prediction reflects an decrease of -6.38% from the last recorded price of $13.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $11.15 | $9.8899 | $11.40 | -15.45% |
| July, 2024 | $11.16 | $10.20 | $11.63 | -15.39% |
| August, 2024 | $9.9998 | $9.9548 | $11.51 | -24.19% |
| September, 2024 | $10.95 | $9.6273 | $11.18 | -16.95% |
| October, 2024 | $10.89 | $10.40 | $11.55 | -17.42% |
| November, 2024 | $13.67 | $10.96 | $13.68 | +3.62% |
| December, 2024 | $13.89 | $13.16 | $14.55 | +5.34% |
Takeda Pharmaceutical Co ADR Stock (TAK) Price Forecast for 2025
Takeda Pharmaceutical Co ADR Stock (TAK) is expected to reach an average price of $10.17 in 2025, with a high prediction of $14.14 and a low estimate of $6.1969. This indicates an -22.90% fall from the last recorded price of $13.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $13.50 | $13.29 | $14.14 | +2.38% |
| February, 2025 | $12.93 | $12.88 | $13.90 | -1.94% |
| March, 2025 | $10.81 | $10.67 | $14.05 | -18.05% |
| April, 2025 | $8.9268 | $6.1969 | $12.24 | -32.32% |
| May, 2025 | $10.75 | $8.2493 | $11.01 | -18.47% |
| June, 2025 | $12.43 | $11.27 | $13.09 | -5.75% |
| July, 2025 | $12.50 | $11.92 | $13.41 | -5.24% |
| August, 2025 | $11.18 | $11.07 | $13.89 | -15.25% |
| September, 2025 | $12.09 | $11.00 | $12.52 | -8.35% |
| October, 2025 | $12.03 | $11.71 | $13.63 | -8.82% |
| November, 2025 | $11.85 | $11.69 | $13.01 | -10.19% |
| December, 2025 | $9.4339 | $9.3469 | $11.97 | -28.48% |
Takeda Pharmaceutical Co ADR Stock (TAK) Price Forecast for 2026
The predicted value for Takeda Pharmaceutical Co ADR (TAK) in 2026 is set at an average of $11.92. Estimates vary from a peak of $14.17 to a trough of $9.6713, indicating an -9.61% surge from the present price of $13.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $12.04 | $9.6713 | $12.08 | -8.69% |
| February, 2026 | $12.98 | $11.80 | $13.20 | -1.56% |
| March, 2026 | $11.57 | $11.38 | $12.81 | -12.25% |
| April, 2026 | $11.84 | $11.33 | $13.10 | -10.23% |
| May, 2026 | $14.01 | $10.75 | $14.09 | +6.23% |
| June, 2026 | $11.47 | $11.22 | $14.17 | -13.03% |
| July, 2026 | $11.39 | $10.62 | $11.52 | -13.66% |
| August, 2026 | $11.51 | $10.81 | $11.84 | -12.75% |
| September, 2026 | $11.08 | $10.70 | $11.66 | -16.03% |
| October, 2026 | $10.68 | $10.65 | $11.64 | -19.06% |
| November, 2026 | $10.99 | $10.62 | $11.39 | -16.71% |
| December, 2026 | $10.81 | $10.73 | $11.74 | -18.02% |
Takeda Pharmaceutical Co ADR Stock (TAK) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Takeda Pharmaceutical Co ADR (TAK) is $9.2781, with a high forecast of $10.87 and a low forecast of $7.6855. This indicates an -29.66% decrease from the last price of $13.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.5331 | $8.3731 | $10.87 | -35.31% |
| February, 2027 | $8.5031 | $8.2756 | $9.0406 | -35.53% |
| March, 2027 | $8.2705 | $7.6855 | $8.4206 | -37.30% |
| April, 2027 | $9.3105 | $8.043 | $9.3105 | -29.41% |
| May, 2027 | $9.2904 | $8.8454 | $9.4404 | -29.56% |
| June, 2027 | $9.6778 | $9.3229 | $9.9654 | -26.63% |
| July, 2027 | $8.9778 | $8.9103 | $9.7929 | -31.93% |
| August, 2027 | $9.0777 | $9.0378 | $9.8528 | -31.18% |
| September, 2027 | $9.4952 | $8.6302 | $9.7952 | -28.01% |
| October, 2027 | $7.8751 | $7.8095 | $9.2126 | -40.29% |
| November, 2027 | $9.1851 | $8.0276 | $9.2751 | -30.36% |
| December, 2027 | $9.0725 | $8.605 | $9.7025 | -31.22% |
Takeda Pharmaceutical Co ADR Stock (TAK) Price Forecast for 2028
In 2028, Takeda Pharmaceutical Co ADR (TAK) is projected to reach an average price of $9.7259, with a high projection of $12.27 and a low estimate of $7.1848. This indicates an -26.26% fall from the last price of $13.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.4324 | $8.3924 | $9.31 | -36.07% |
| February, 2028 | $7.8524 | $7.6324 | $8.6874 | -40.47% |
| March, 2028 | $8.1398 | $7.1848 | $8.5049 | -38.29% |
| April, 2028 | $9.5298 | $7.9173 | $9.5498 | -27.75% |
| May, 2028 | $10.53 | $9.3582 | $10.54 | -20.19% |
| June, 2028 | $11.29 | $10.28 | $11.32 | -14.43% |
| July, 2028 | $11.10 | $10.68 | $11.32 | -15.87% |
| August, 2028 | $11.01 | $10.26 | $11.26 | -16.49% |
| September, 2028 | $12.18 | $10.93 | $12.26 | -7.62% |
| October, 2028 | $12.01 | $11.65 | $12.10 | -8.91% |
| November, 2028 | $11.30 | $10.84 | $12.27 | -14.31% |
| December, 2028 | $10.92 | $10.73 | $11.56 | -17.20% |
Takeda Pharmaceutical Co ADR Stock (TAK) Price Forecast for 2029
The 2029 price forecast for Takeda Pharmaceutical Co ADR Stock (TAK) is $8.2883 on average, with a high prediction of $11.71 and a low estimate of $4.87. This represents an -37.16% decrease from the previous price of $13.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.51 | $10.42 | $11.05 | -20.32% |
| February, 2029 | $10.51 | $10.18 | $10.75 | -20.32% |
| March, 2029 | $11.63 | $10.43 | $11.67 | -11.83% |
| April, 2029 | $10.48 | $9.8766 | $11.71 | -20.55% |
| May, 2029 | $9.0665 | $8.544 | $10.43 | -31.26% |
| June, 2029 | $9.5765 | $8.934 | $9.5765 | -27.40% |
| July, 2029 | $9.7064 | $9.0764 | $9.7264 | -26.41% |
| August, 2029 | $10.07 | $9.5639 | $10.52 | -23.63% |
| September, 2029 | $10.12 | $9.3338 | $10.38 | -23.25% |
| October, 2029 | $9.9512 | $9.8437 | $10.40 | -24.55% |
| November, 2029 | $8.8112 | $8.6812 | $9.9987 | -33.20% |
| December, 2029 | $6.59 | $4.87 | $8.9887 | -50.04% |
Takeda Pharmaceutical Co ADR Stock (TAK) Price Forecast for 2030
Takeda Pharmaceutical Co ADR Stock (TAK) is expected to reach an average price of $4.1077 in 2030, with a high forecast of $8.1792 and a low forecast of $0.0363. This signifies an -68.86% decrease from the last price of $13.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.9499 | $3.3199 | $6.665 | -70.05% |
| February, 2030 | $4.6898 | $3.7898 | $5.0948 | -64.44% |
| March, 2030 | $4.9347 | $3.6897 | $5.0347 | -62.59% |
| April, 2030 | $3.8896 | $3.1546 | $4.9896 | -70.51% |
| May, 2030 | $4.2494 | $3.9445 | $5.1044 | -67.78% |
| June, 2030 | $4.9243 | $3.9794 | $4.9493 | -62.67% |
| July, 2030 | $7.6292 | $4.7193 | $8.1792 | -42.16% |
| August, 2030 | $7.4541 | $7.3191 | $8.0792 | -43.49% |
| September, 2030 | $7.279 | $6.959 | $7.474 | -44.81% |
| October, 2030 | $6.9138 | $6.5939 | $7.7739 | -47.58% |
| November, 2030 | $2.2687 | $1.8687 | $7.1638 | -82.80% |
| December, 2030 | $2.1336 | $0.0363 | $3.1987 | -83.82% |
2.11%
3.99%
Cap:
|
Volume (24h):